Immune CHeckpoint Inhibitors Monitoring of Adverse Drug ReAction

Clinical trial NCT03492242 · COMPLETED

Trial details

NCT number: NCT03492242
Sponsor: Groupe Hospitalier Pitie-Salpetriere
Status: COMPLETED
Study type: OBSERVATIONAL

Arthritis Cancer Cardiac Disease Endocrine System Diseases Autoimmune Diseases Ophthalmopathy Myositis Neuropathy

Start date: 2018-02-01
Primary completion: 2018-09-30
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.